Letters, Testimony & Comments

March 30, 2001
Summary of Testimony of Thomas Okarma, MD, PhD BIO opposes human reproductive cloning. It is too dangerous technically and raises too many ethical and social questions. The voluntary moratorium on human reproductive cloning should remain in...
February 1, 2001
Dear Mr. President: Recently certain groups have announced plans to clone human beings. The Biotechnology Industry Organization (BIO) opposes these efforts, and we urge you to support continuation of the current voluntary moratorium on these...
February 1, 2001
By Dan Eramian Vice President Communications Biotechnology Industry Organization Delivered at the Global Public Affairs Institute Johnson & Johnson New Brunswick, New Jersey February 1, 2001 Good Morning … thank you for...
January 17, 2001
President-Elect George W. Bush Bush-Cheney Transition Headquarters 1800 G Street, N.W. Washington, DC 20270 Dear President-Elect Bush: The undersigned 123 patient, research, and academic institutions, write to express their strong support...
December 12, 2000
The Biotechnology Industry Organization (BIO) submits these comments on the proposal published by the National Institutes of Health (NIH) in 65 Fed. Reg. 77655 (December 12, 2000), to revise the "NIH Guidelines for Research Involving...
July 13, 2000
WASHINGTON, D.C. (July 13, 2000) -- Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary subcommittee oversight hearing on gene patents and other genomic inventions. In his...
June 1, 2000
By Carl B. Feldbaum, President Ladies and Gentlemen, I'm Carl Feldbaum, President of the Biotechnology Industry Organization, otherwise known as BIO. I want to welcome you here to Boston, and to BIO 2000, which is by far our largest, and...
April 26, 2000
Testimony of Joanna C. Horobin, MD Executive Vice President For Commercial Development EntreMed Inc. on behalf of Biotechnology Industry Organization (BIO) Before the Senate Health, Education, Labor and Pensions Committee RE: The Proposed...
March 10, 2000
Good afternoon. My name is Michael Werner. I am bioethics counsel for the Biotechnology Industry Organization (BIO). BIO represents more than 900 biotechnology companies, academic institutions, and state biotechnology centers engaged in...
February 15, 2000
Dear Dr. Hamburg: The Biotechnology Industry Organization ("BIO") is pleased to offer the following comments regarding proposed federal standards for protecting the privacy of individually identifiable health information maintained or...
February 2, 2000
Good morning. I am Stewart Parker, CEO of Targeted Genetics Corporation, a biotechnology company based in Seattle, Washington. I am testifying on behalf of the Biotechnology Industry Organization (BIO), which represents 850 companies, academic...
January 31, 2000
Dear Dr. McCabe: The Biotechnology Industry Organization (BIO) represents 850 companies, academic institutions and state biotechnology centers engaged in biotechnology research on medicines, diagnostics, agriculture, pollution control and...
July 1, 1999
Executive Summary The Biotechnology Industry Organization (BIO) supports reforms of the Hatch Waxman Act that will provide full day-for-day restoration of lost patent term for drugs which require extended reviews and/or clinical trials for FDA...
May 27, 1999
The Biotechnology Industry Organization (BIO) is encouraged that the Subcommittee on Health and the Environment of the House Commerce Committee is holding this hearing and working to develop legislation to protect the confidentiality of patient...
March 25, 1999
Executive Summary BIO supports amendments to the patent law that, above all, ensure that diligent patent applicants are not penalized for delays which are beyond their control. BIO has been working in support of amendments that will preserve the...
March 22, 1999
Harold Shapiro, Ph.D. Chairman c/o E. Randolph Hull National Bioethics Advisory Commission 6100 Executive Blvd., Suite 5B01 Rockville, MD 20892-7508 Dear Dr. Shapiro: Thank you for the opportunity to submit comments for NBAC's report...
January 12, 1999
EXECUTIVE SUMMARY Pluripotent stem cells research provides the hope of a new generation of therapeutics. Using cell transplants instead of drugs, biologics and other current therapies, provides new hope for patients with cancer, spinal cord...
March 27, 1997
March 27, 1997 The Honorable William J. Clinton President of the United States The White House Washington, D.C. 20500 Dear Mr. President: The recent cloning of a sheep from the genetic material of an adult cell has riveted the world....
Re: Review of the Declaration of Helsinki   Dear Sir or Madam:   BIO appreciates the opportunity to comment on the World Medical Association’s (WMA’s) Declaration of Helsinki. The Biotechnology Industry Organization (...